老粉表示很好用
很方便的诊股工具啊，特别省事，不用在网上到处找想看的股票的信息了
Description
诊股宝是格隆汇为2000万+高净值投资者倾力打造的专业诊股工具，利用大数据、人工智能等为用户提供高效迅捷的信息处理、投资线索挖掘等服务，通过财务数据、交易数据、估值情况等数据，打造一款全方位的智能诊断系统。
【投资亮点/风险提示】
凝炼出极具价值的18个指标，这些指标大都是判断股票是不是金子的核心指标；
从盈利能力、收益质量、负债、成长能力、估值、资产质量、分红情况等多方面解读个股。
【机构目标价、机构评级】
通过计算近三个月各机构对该股票目标价做出的平均预计值来判断个股的上涨空间；
通过分析近三个月各投资机构的投资评级，来了解机构对个股的看法。
【估值情况】
查看股票近十年的估值情况，以及目前估值处于近十年的位置，从而判断股票是否高估或者低估。
【扫雷指标】
从销售收现率、收益质量、资产负债率、流动比率、速动比率、商誉占比这六个方面来判断该公司是否有潜在的投资风险。
Hide
Show More...
【投资亮点/风险提示】
凝炼出极具价值的18个指标，这些指标大都是判断股票是不是金子的核心指标；
从盈利能力、收益质量、负债、成长能力、估值、资产质量、分红情况等多方面解读个股。
【机构目标价、机构评级】
通过计算近三个月各机构对该股票目标价做出的平均预计值来判断个股的上涨空间；
通过分析近三个月各投资机构的投资评级，来了解机构对个股的看法。
【估值情况】
查看股票近十年的估值情况，以及目前估值处于近十年的位置，从而判断股票是否高估或者低估。
【扫雷指标】
从销售收现率、收益质量、资产负债率、流动比率、速动比率、商誉占比这六个方面来判断该公司是否有潜在的投资风险。
Screenshots
诊股宝-投资者必备的诊股神器 FAQ
-
Is 诊股宝-投资者必备的诊股神器 free?
Yes, 诊股宝-投资者必备的诊股神器 is completely free and it doesn't have any in-app purchases or subscriptions.
-
Is 诊股宝-投资者必备的诊股神器 legit?
Not enough reviews to make a reliable assessment. The app needs more user feedback.
Thanks for the vote -
How much does 诊股宝-投资者必备的诊股神器 cost?
诊股宝-投资者必备的诊股神器 is free.
-
What is 诊股宝-投资者必备的诊股神器 revenue?
To get estimated revenue of 诊股宝-投资者必备的诊股神器 app and other AppStore insights you can sign up to AppTail Mobile Analytics Platform.
User Rating
App is not rated in Norway yet.
Ratings History
诊股宝-投资者必备的诊股神器 Reviews
ty
很不错的软件，对研究公司基本面很有帮助，不过希望还可以更丰富一点～
有用
查代码什么的都很方便，推荐✅
方便好用
查股票信息 方便 快捷 全面
价值投资必备
股票的亮点，风险，估值等等炒股用到的指标都有。价值投资必备呀，很棒。
还挺实用的~
嗯
Store Rankings
Ranking History
App Ranking History not available yet
Category Rankings
App is not ranked yet
诊股宝-投资者必备的诊股神器 Competitors
诊股宝-投资者必备的诊股神器 Installs
Last 30 days
诊股宝-投资者必备的诊股神器 Revenue
Last 30 days诊股宝-投资者必备的诊股神器 Revenue and Downloads
Gain valuable insights into 诊股宝-投资者必备的诊股神器 performance with our analytics.
Sign up now to access downloads, revenue, and more.
Sign up now to access downloads, revenue, and more.
App Info
- Category
- Finance
- Languages
- English
- Recent release
- 1.3.1 (8 months ago )
- Released on
- Aug 25, 2020 (4 years ago )
- Also available in
- China, Hong Kong SAR China, Philippines, Poland, Peru, New Zealand, Norway, Netherlands, Nigeria, Malaysia, Mexico, Lebanon, Kazakhstan, Kuwait, South Korea, Japan, Italy, Pakistan, India, Portugal, Romania, Russia, Saudi Arabia, Sweden, Singapore, Slovakia, Thailand, Türkiye, Taiwan, Ukraine, United States, Vietnam, South Africa, Dominican Republic, Argentina, Austria, Australia, Azerbaijan, Belgium, Brazil, Belarus, Canada, Switzerland, Chile, Colombia, Czechia, Germany, Denmark, Iceland, Algeria, Ecuador, Egypt, Spain, Finland, France, United Kingdom, Greece, Croatia, Hungary, Indonesia, Ireland, Israel, United Arab Emirates
- Last Updated
- 1 month ago
This page includes copyrighted content from third parties, shared solely for commentary and research in accordance with fair use under applicable copyright laws. All trademarks, including product, service, and company names or logos, remain the property of their respective owners. Their use here falls under nominative fair use as outlined by trademark laws and does not suggest any affiliation with or endorsement by the trademark holders.